RedHill Biopharma Ltd.

Home » RedHill Biopharma Ltd.

Secondary

RedHill Biopharma Ltd.

They are a specialty biopharmaceutical company, primarily focused on the development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for the treatment of gastrointestinal and inflammatory diseases and cancer.

Symbol

RDHL

Last Closing Price
$7.50

Shares
2,000,000

Effective Date
November 8, 2017

Underwriters
Cantor Fitzgerald, Nomura

To view the prospectus for RedHill Biopharma Ltd., or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253